PEPVERAAUTHENTIC HIGH-QUALITY PEPTIDES
SIGN IN
Larazotide
REPAIR · V

Larazotide

Tight-junction stabilizer.

From / per milligram
$80$—/mg · 10MG
Sizes available
—
Lab certificate (COA)
Arrives with shipment
View test certificate →

· Research-grade only · Not for human consumption · 21+ ·

What is it

Tight-junction modulator. Investigational therapy for leaky gut and celiac (oral capsule).

Mechanism · Octapeptide zonulin antagonist. Celiac Phase 3 (Innovate Biopharmaceuticals).

Who

Best for. Not for.

Best for

  • Celiac adjunct for accidental gluten exposure.
  • Leaky-gut syndrome research.
  • Users who prefer an oral capsule.

Not for

  • Pregnancy or nursing.
  • Phase 3 failed its primary endpoint in 2022. Efficacy remains uncertain.
  • Severe gluten allergy (does not replace gluten avoidance).
What it does

Mechanism, dose, ramp, risk.

Mechanism
Gut tight-junction modulator. Studied for celiac.Source · PEPVERA editorial
Target dose
0.5 mg, oral, before meals.Source · PEPVERA editorial
Ramp
Daily.Source · PEPVERA editorial
Risks
Trial-stage data.Source · PEPVERA editorial
Alternatives

Compared to its siblings.

★ Currently viewing

Larazotide

Tight-junction modulator. Investigational therapy for leaky gut and celiac (oral capsule).

Pros

  • · Human Phase 3 trial data; KPV and BPC-157 rely on animal data.

Cons

  • · Narrower coverage than KPV (no skin indication).
  • · Less broad evidence than BPC-157 across tissues.

KPV

Different mechanism. α-MSH anti-inflammatory.

Pros

  • · Broader gut and skin coverage.

Cons

  • · Animal data only.

See KPV →

BPC-157

Gastric BPC. Different mechanism.

Pros

  • · Broad animal data.

Cons

  • · No human RCT.

See BPC-157 →

How we verify

COA per supplier

Published, in-house, or shipment-time

Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.

→ How we verify suppliers→ Refund policy
GutAnti-inflamExperimental
Suppliers

Compare 0 suppliers

No verified suppliers yet for this compound.

❄ COLD-CHAIN · 5–9 DAYS

Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.

Dosing protocol

Week 1

0.5 mg, oral, before meals.

Begin near site

Week 2–4

0.5 mg, oral, before meals.

Daily, rotate

Week 5–6

0.5 mg, oral, before meals.

Taper option

Week 7+

Maintenance

As needed

Reconstitution

Draw 20 units.

1 mg = 0.20 mL at 5.00 mg/mL. 10.0 doses per vial.

repair · V

Larazotide · 10mg